In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Carsten Tschoepe
Speaker
Carsten Tschoepe
Carsten Tschoepe Carsten Tschoepe

Charite - Campus Virchow-Klinikum (CVK), Berlin (Germany)

Speciality : Acute Heart Failure

32 presentations from this speaker

Fibrosis and inflammation.

Event : Heart Failure 2019

  • Session : Hypertrophic cardiomyopathies: from gene to disease
  • Speaker : C Tschoepe (Berlin,DE)

Hypertrophic cardiomyopathy: clinical phenotypes.

Event : Heart Failure 2019

  • Session : Heart failure in cardiomyopathies: differences in diagnosis and management
  • Speaker : C Tschoepe (Berlin,DE)

New devices to treat HFpEF ?

Event : ESC Congress 2019

  • Session : New hope for HFpEF patients
  • Speaker : C Tschoepe (Berlin,DE)

Viruses: innocent bystanders?

Event : Heart Failure 2019

  • Session : Dilated cardiomyopathies: what are the mechanisms?
  • Speaker : C Tschoepe (Berlin,DE)

A patient with HFpEF and diabetes - Wrap-up and take home message

Event : Heart Failure 2018

  • Session : Guidelines in daily practice V - HFpEF
  • Speaker : C Tschoepe (Berlin,DE)

Endomyocardial biopsy is needed for most patients with myocarditis.

Event : ESC Congress 2018

  • Session : Myocarditis: do we need endomyocardial biopsy?
  • Speaker : C Tschoepe (Berlin,DE)

How to differente myocarditis vs dilated cardiomyopathy?

Event : Heart Failure 2018

  • Session : The many faces of myocarditis
  • Speaker : C Tschoepe (Berlin,DE)

Immunosuppression in lymphocytic myocarditis with parvovirus B19 presence

Event : Heart Failure 2018

  • Session : Myocardial Disease – Clinical
  • Speaker : C Tschoepe (Berlin,DE)

Mechanical unloading as a novel treatment option for chronic inflammatory cardiomyopathy

Event : Heart Failure 2018

  • Session : Myocardial Disease – Clinical
  • Speaker : C Tschoepe (Berlin,DE)

Repetitive use of inodilators in advanced heart failure: scientific evidence in the literature.

Event : Heart Failure 2018

  • Session : Repetitive use of inodilators in advanced heart failure
  • Speaker : C Tschoepe (Berlin,DE)
  • Sponsored by Orion Pharma

Repetitive use of inodilators in advanced heart failure: scientific evidence in the literature.

Event : Heart Failure 2018

  • Session : Repetitive use of inodilators in advanced heart failure
  • Speaker : C Tschoepe (Berlin,DE)
  • Sponsored by Orion Pharma

When is an invasive evaluation of suspected HFpEF indicated?

Event : Heart Failure 2018

  • Session : HFpEF - The new HFA consensus
  • Speaker : C Tschoepe (Berlin,DE)

Diagnosis.

Event : Heart Failure 2017

  • Session : How to diagnose and treat myocarditis?
  • Speaker : C Tschoepe (Berlin,DE)

Effective ventricular unloading leading to recovery after acute myocarditis.

Event : ESC Congress 2017

  • Session : Percutaneous ventricular assist devices for heart recovery
  • Speaker : C Tschoepe (Berlin,DE)
  • Sponsored by Abiomed Europe GmbH

How to establish the diagnosis of HFpEF

Event : ESC Congress 2017

  • Session : Heart failure with preserved ejection fraction - A clinical dilemma
  • Speaker : C Tschoepe (Berlin,DE)

Improvement to heart failure with mid-range ejection fraction - Conclusion and take home message.

Event : ESC Congress 2017

  • Session : Heart failure with mid-range ejection fraction - What does it mean for clinical practice?
  • Speaker : C Tschoepe (Berlin,DE)

CCM mechanism of action, and future developments into HFpEF.

Event : Heart Failure 2016

  • Session : Present and future of device therapy in heart failure
  • Speaker : C Tschoepe (Berlin,DE)
  • Organised by Charité Medical School Berlin, supported by an unrestricted educational grant from Impulse Dynamics

Cellular therapy: are we there yet?

Event : ESC Congress 2016

  • Session : Translational approach to heart failure
  • Speaker : C Tschoepe (Berlin,DE)
  • Joint with the American Heart Association

Future direction for research in heart failure with preserved ejection fraction.

Event : ESC Congress 2016

  • Session : Heart failure with preserved ejection fraction
  • Speaker : C Tschoepe (Berlin,DE)

Role of S100A8 and S100A9 alarmins in Coxsackievirus B3-induced myocarditis

Event : Heart Failure 2016

  • Session : Basic Science: Cardiomyopathy
  • Speaker : C Tschoepe (Berlin,DE)

Standard therapy in 2016.

Event : Heart Failure 2016

  • Session : Myocarditis: update 2016
  • Speaker : C Tschoepe (Berlin,DE)

Cardiac fibroblasts, inflammation and heart failure

Event : ESC Congress 2015

  • Session : Cross-talk between cardiovascular and non-cardiovascular cells in disease pathogenesis
  • Speaker : C Tschoepe (Berlin,DE)
  • ESC and the British Society for Cardiovascular Research

Cardiac resonance is useful in diagnosis or rule-out of myocarditis - CONTRA.

Event : ESC Congress 2015

  • Session : Debates in advances imaging for patient management
  • Speaker : C Tschoepe (Berlin,DE)

Cardiac resonance is useful in diagnosis or rule-out of myocarditis - REBUTTAL CONTRA.

Event : ESC Congress 2015

  • Session : Debates in advances imaging for patient management
  • Speaker : C Tschoepe (Berlin,DE)

Myocarditis - Take home message.

Event : ESC Congress 2015

  • Session : Myocarditis
  • Speaker : C Tschoepe (Berlin,DE)

Myocarditis.

Event : ESC Congress 2015

  • Session : Reversible cardiomyopathies: what we know and what we don't.
  • Speaker : C Tschoepe (Berlin,DE)

How to recognise it?

Event : ESC Congress 2014

  • Session : Challenges in heart failure with preserved ejection fraction
  • Speaker : C Tschoepe (Berlin,DE)

Administration of regulatory T cells ameliorates myocardial inflammation in experimental myocarditis

Event : ESC Congress 2013

  • Session : Stem cells and development
  • Speaker : C Tschoepe (Berlin,DE)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are